window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Stem Cell Therapy

  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain,Therapeutic Areas

    CellProthera acquires full rights to transendocardial catheter from Celyad Oncology

    CellProthera has acquired full rights to the transendocardial catheter originally [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics

    CellProthera publishes Phase 1/2b results of stem cell therapy for post-heart attack patients

    CellProthera has published peer-reviewed results from its phase 1/2b Excellent [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    PL BioScience opens new headquarters to support growing demand for HPL production

    1,200 m² Aachen facility will enable largest global HPL output [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain

    Celularity and Fountain Life partner to deliver stem cell therapies under new Florida Law

    Celularity and Fountain Life have formed a strategic partnership to [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development

    Novadip’s autologous cell therapy NVD003 receives RMAT designation for rare pediatric bone disorder

    FDA recognises regenerative approach for congenital pseudarthrosis of the tibia [...]

    May 5, 2026
  • Advanced Therapies

    Cycuria Therapeutics launches with advisory board and major grant funding

    May 5, 2026
  • Clinical & Regulatory

    Novadip’s ‘off-the-shelf’ spine fusion product shows early efficacy and safety in studies

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Therapeutic Areas
  • Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top